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Abstract 
Skin act as a major target as well as a principle barrier for transdermal drug delivery. 
Vesicular system is one of the most promising approaches for transdermal delivery of active 
substances. Liposomes are most commonly used vesicular delivery system. But it has certain 
limitations such as lesser stability, reduced encapsulation efficiency, etc led to formulation of 
ethosomes. In the present work we encapsulated various concentration of ketoconazole (an 
antifungal drug) within ethosome and liposome and made a comparative evaluation of their 
morphology, size, potential, stability and anti-fungal efficacy. Ethosomes showed better 
stability, encapsulation efficiency and anti-fungal activity as compared to liposome due to its 
ethanolic content. So ethosomal formulation may prove as a very promising option for 
transdermal delivery and has potential for new opportunities for topical application of 
ketoconazole in the fungal infections. 
Key words: drug delivery, transdermal, encapsulation efficiency, topical, ketoconazole 
liposome, ethosome. 
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Chapter 1 
INTRODUCTION 
Nanotechnology is a multidisciplinary field that covers a vast and diverse array of devices 
derived from engineering, physics, chemistry, and biology (Sahoo.S.K., et al, 2006). It is the 
technique of manipulating matter at the scale of atom and molecules (Drexler et al., 1986). In 
1974 Norio Taniguchi used the phrase “nanotechnology” for the first time while describing 
an ion sputter machine. The term “nano” which means “dwarf” was originally derived from 
Greek word. Nanotechnology works with materials, devices, and other structures with at least 
one dimension sized from 1 to 100 nanometres. Nanometre is defined as one billionth of a 
metre that is equivalent to the length of ten hydrogen atoms. Now a day’s nanotechnology has 
a global interest. As mentioned in Environmemt and green nano the term nanotechnology 
embraces various fields and specialities including green nanotechnology, wet 
nanotechnology, nanoengineering, nanobiotechnology. Application of nanotechnology in 
commercial products like nanomedicine and green technology minimizes energy 
consumption and enhances the environmental sustainability of processes currently producing 
negative externalities, thus increasing the efficiency of energy production or quantum aged 
atoms (QCAs) (Robert A. Freitas Jr. 1999). Nanotechnology also has numerous potential 
application in the fields of consumer goods, providing with products with novel functions 
ranging from easy to clean to scratch-resistant (Neethirajan et.al., 2009) .   
 
The structural and functional unit of nanotechnology is nanoparticle. It is defined as a small 
object that behaves as a whole unit with respect to its transport and properties. According to 
their diameter particles are further classified into three categories.(Grangvist et al., 1976).  
 Coarse particles (10,000-2,500 nm) 
 Fine particles (100-2500 nm) 
 Ultrafine particles (1-100 nm) 
 
Various types of nanoparticles are present which includes Nanosphere, Nanocapsule, 
Dendrimer, Polymeric micelles, Liposome and  SLN (solid lipid nanoparticles). Nanosphere 
are considered as a matrix system in which matrix is uniformly dispersed. Beside of these 
spherical vesicular system is known as nanocapsules. In case of polymeric nanoparticles, the 
polymeric membrane surrounds the drug in a matrix core. Mostly biodegradable polymers are 
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used in polymer nanoparticles likes polycyanoacrylate or poly (D, L-lactide) and related 
polymers like poly(lactic acid)PLA or poly(lactide-co-glycolide) etc. Dendrimers is a unique 
class of polymers which is highly branched macromolecules whose size and shape can be 
precisely controlled. Application of nanoparticles target drug delivery, drug bio-availability, 
detection of pathogen etc (Abhilash M,. 2010). 
Phospholipids are the major components of all cell membranes as they form lipid layers. 
Phospholipid is a class of lipid mainly consisting of diglyceride and phosphate group. The 
structure of the phospholipid molecule consists of hydrophobic tails and a hydrophilic head. 
Lecithin or phosphatidylcholine from egg yolk was the first identified phospholipid. Other 
common phospholipids are phosphatidic acid (phosphatidate), phosphatidyethanolamine 
(cephalin), phosphatidylcholine (lecithin), phosphatidylserine, phosphoinositides, etc. 
Phospholipid synthesis occurs in the cytosol adjacent to endoplasmic reticulum (ER) (E Fahy 
et al., 2009). 
 
Lecithin (phosphatidylcholine) is generic term which is used to designate yellow brownish 
fatty substance present in animal or plant tissue composed of phospholipids, phosphoric acid, 
triglyceride, glycolipids, etc. Lecithin is easily extracted from sources such as soybeans, eggs, 
milk, marine sources, rapeseed, cottonseed and sunflower chemically by using hexane, 
ethanol, etc. Lecithin has emulsification and lubricant properties. Lecithin from soybean and 
egg play an important role in drug delivery.  
 
Liposome is an artificial microscopic single vesicle consisting of an aqueous core enclosed in 
one or more phospholipid layers used to convey vaccines, drugs, enzymes, or other 
substances to target cells or organs (Lawerence D, 1986). Liposomes are a form of 
nanoparticle prepared from lecithin. They are microscopic, concentric bilayered vesicles. 
Here the aqueous volume is entirely enclosed by a membraneous lipid bi-layer composed of 
natural or synthetic phospholipids. The major types of liposomes are multilamellar vesicles, 
small unilamellar vesicles, large unilamellar and cochleate vesicles (Sharma.A and Sharma 
U.S, 1997). Liposomes increase the efficiency, bioavailability, absorption of certain 
entrapped dietary and nutritional supplements and are used as topical drug delivery system.     
(C.George et al., 1975). But liposomal drug delivery system has certain shortcomings like the 
need for modification for site specific or organ specific drug delivery, high production cost 
and leakage and fusion of encapsulated drug/molecule. Moreover unfavourable reactions like 
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oxidation and hydrolysis of phospholipids reduces the half life of the formulation, decreases 
solubility and stability of drug in the medium (Sirisha.V.N et al., 2012). Demerits of 
liposome in skin delivery include a limited ability to penetrate narrow blood vessels or into 
skin to a significant degree. Some time the materials which one we want to deliver into skin 
may get entrapped in the inner layers of the liposomes while in certain conditions are 
virtually un- releaseable (Ralp Hill, 2011) 
 
To overcome these shortcomings a modified form of liposome is used termed as ethosome. 
Ethosomes are ethanolic phospholipids vesicles, which have higher penetration rate through 
the skin than liposomes. It has higher penetration rate, high efficiency or bio-availability due 
to its ethanolic contents. Ethosome vesicles contain phospholipids and alcohol (in relatively 
in high concentration) (Gangwar Satyam et al., 2010).  
 
Ethosome represents novel vesicular carrier for enhanced delivery through skin. Size of 
ethosome may vary from 30nm to a few microns. Ethosome has its ability to permeate intact 
through the human skin due to its high deformability. The physicochemical characteristics of 
ethosome allow this vesicular carrier to transport active substances more efficaciously 
through the stratum corneum into the deeper layers of the skin than conventional liposomes. 
Ethosome mainly used for delivery of drug through transdermal route. Advantages of 
ethosome such as enhanced permeation of drug molecules to and through the skin, better 
stability, better solubility of many drugs as compared to conventional vesicles, contrary to 
deformation liposomes improves skin delivery of drugs  (Bharti et al., 2012). 
 
Some common drugs administered by transdermal route include NSAIDS (Diclofenac), 
Acyclovir, Antibiotic, Cannabidol, Zidovudine, Ketoconazole, (Dave and Pareek, 2012).  
Ketoconazole is a synthetic antifungal drug which is used to treat fungal infection of skin. 
Chemical formula of ketoconazole is C26H28Cl2N4O4 and its molecular weight is 531.43. 
Ketoconazole is marketed under trade name Nizoral. Some brand names are Nizoral topical, 
Xolegel, Kuric, Nizoral A-D. Nizoral tablet (200mg) which are pure of ketoconazole are 
easily available in market. Ketoconazole interferes with the fungal synthesis of ergosterol. 
Ergosterol is a constituent of fungal cell membrane. It also inhibits enzyme cytochrome P450 
14 alpha demethylase (P450 14 DM) (Loose et al., 1983). Infections treated by ketoconazole 
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include blastomycosis, histoplasmosis, yeast infection (Malassezia), and Dermatophytes 
infections (ringworm).  
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OBJECTIVES 
1. To prepare ethosomes and liposomes encapsulating ketoconazole in various 
concentrations. 
2. To characterize the prepared ethosome and liposome. 
3. To determine the efficacy of prepared ethosome and liposome against fungal 
pathogens. 
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Chapter2 
2.1 NANOTECHNOLOGY:  
                        “There’s plenty of room at the bottom.” -Richard Feynman. 
Feynman was the first who inspired conceptual beginnings of the nanotechnology. Research 
and technological development of manipulating matter at the atomic, molecular or 
macromolecular levels, in the length scale of approximately 1-100 nanometre (nm) range in 
any direction. Nanotechnology has been defined in various ways according to various fields. 
According to the NASA’s definition “Nanotechnology is the creation of functional materials, 
device and systems through control of matter on the nanometre length scale (1-
100nanometers), and exploitation of novel phenomenon and properties (physical, chemical, 
biological, mechanical, electrical, biomedical...) at that length scale”. The term “nano” which 
means “dwarf” was originally derived from Greek word. In mathematical expression nano 
means 10
-9
. The term nanotechnology was first used by Professor Norio Taniguchi at the 
University of Tokyo, 1971 in regards to ion sputter machine. According to Professor Norio 
Taniguchi “Nanotechnology is the production technology to get extra high accuracy and 
ultrafine dimensions, i.e. the preciseness and fineness on the order of 1 nm (nanometer), 10
-9
 
meter in length (Taniguchi 1974). In the 1980s, Eric Drexler authored the landmark book on 
nanotechnology, “Engines of Creation” (Drexler 1986), in which he described the concept of 
molecular manufacturing to the public at large. By the 1990s, nanotechnology was advancing 
rapidly.  
2.1.1 Types:  
 The term nanotechnology according to the journal of Environment and Green Nano of 2011, 
embraces various fields and specialities including Green nanotechnology, Wet 
nanotechnology, Nanoengineering,  Nanobiotechnology, etc.  
Green synthesis technology: Technology which is used to enhanced environment 
sustainability or developed clean technology in order to minimize human health and 
production of new nano-products which helps to makes the environment friendlier. Green 
technology heightens the environment sustainability that is producing negative exteriorities. 
Green technology is basically about making green nano products. Two main goals of green 
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nanotechnology are producing nanomaterials or products without harming human health or 
environment, producing nano-products that provide solution for environmental problems.  
Wet technology: The study of biological system that occurs primarily in water environment. 
The functional nanostructure of interest here are genetic material, enzyme and cellular 
membrane etc. Wet technology always exists in water environment (Eric Dexler, 1986).  
Nanoengineering: It is the practice of engineering on the nanoscale.  Nanoscale is one 
billionth of a metre, i.e. the length of ten hydrogen atoms. Nanoengineering is a 
interdisciplinary science that deals with building biochemical structure smaller than 
bacterium, which function like microscopic factories at atomic or molecular level.  
2.1.2 Applications: 
Nanotechnology is helping to considerably improve, even revolutionize, many technology 
and industrial sectors: energy, environmental science, information technology, medicine, 
homeland security, food safety, and transportation, among many other. Nanotechnology have 
various applications in various fields like physics, chemistry, medical, environment etc. 
Application of nanotechnology in physics:  
 
Lasers modulators for telecommunication, computer peripherals (e.g. VCSEL= Vertical 
Cavity Surface Emitting Laser),  sunscreens with nanoparticles,  nanocatalyts,  “lab-on-chip” 
diagnostics, biomaterials, electronic displays ( “intelligent ink on paper”), Intel nano 
transistors. It also has numerous potential application in the field of consumer goods, 
providing with products with novel functions ranging from easy to clean to scratch-resistant 
(Neethirajan et.al. 2009). Nanotechnology is already being used in numerous kinds of 
batteries that are less flammable, more efficient, lighter weight. 
 
Application of nanotechnology in chemistry:  
 It should be bracing to chemists to realize that chemistry is playing a leading role in 
nanotechnology. Steel is a very important and widely used material and has major role in the 
construction industry. Nanotechnology helps to improve the properties of steel. 
Nanotechnology helps to solve out the problem which led to the structural failure of steel due 
to cyclic loading, such as in bridges or towers (kuennen, 2004). Current steel designs are 
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based on the reduction in the allowable stress and service life or regular inspection regime, 
etc. Advancements in this technology using nanoparticles would lead to more efficient 
materials free from fatigue, increased safety, less need for regular inspection regime. 
Application of nanotechnology in environmental science: 
Nanotechnology helps to increase the efficiency of fuel production from normal to lower 
grade materials. It also help meet the need for , clean drinking water through rapid, low cost 
detection of impurities in and filtration and purification of water. Bacterial identification and 
elimination in which nano carbohydrate particles bind with bacteria so they can be detected 
and eliminated is used to minimize and enhance the environmental sustainability of process 
currently producing negative externalities. Increasing the efficiency of energy production  or 
it  could lead to a strong reduction of energy consumption for illumination by nantechnology 
(Robert A. Freitas Jr. 1999). 
Application of nanotechnology in medical science:  
 
Nanotechnology is widely used for drug delivery, gene therapy, detection of disease causing 
organism, diagnosis, etc. Nanotechnology is used to treat cancer by involving targeted 
chemotherapy that delivers a tumour killing agent called tumour necrosis factor alpha(TNF) 
which is attached with gold nanoparticles, nanotechnology is also used for imaging and 
detection of diseases (Gunasekera A, 2009).  The use of nanotechnology in these areas of 
medicine is one broken bones and for cell reparation can lead to better and faster healing of 
the body. Nanotechnology in medicine involves applications of nanoparticles currently under 
development, as well as longer range research that involves the use of manufactured nano-
robots to make repairs at the cellular level. 
 
2.2 NANOPARTICLES 
The structural and functional unit of nanotechnology is known as nanoparticles. Michael 
Faraday provided the first description about properties of nanometre –scale metals in his 
1857 paper. A small object that behaves as the whole unit with respect to properties and 
transport is called as a nanoparticles. On the basis of diameter particle are classified into three 
categories (Grangvist et al., 1976). Coarse particles cover a range between 10,000-2,500 
nanometre, fine particles ranges in between 100-2500 nanometre and ultra fine particles 
range between 1-100 nanometre. 
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2.2.1 Types: 
Any microscopic particle less than about 100 nanometers (nm) in diameter is nanoparticle. 
Nanoparticles can be manmade to posses highly desired and specific properties. Types of 
nanoparticles include Quantum Dots, Carbon Nanotubes (Buckyballs), Nanorods, 
Nanocrystals, Nanowires, Nanoribbons, etc.  
Quantum Dot is a portion of matter whose excitation is confined in all three spatial 
dimensions. These materials have electronic properties (Brus L.E, 2007). Allotropes of 
carbons with a cylindrical nanostructure are called as carbon tubes. Nanotubes have been 
constructed with length-to-diameter ratio of up to 132,000,000:1 (Wang et al., 2009).  
Nanocrystal is also called as crystalline nanoparticles. Nanocrystal as any single crystalline 
nanomaterial have at least one dimension less than or equal to 100nm (Fahlman., 2007). 
Nano ribbons are also called as nano-graphene ribbons (GNRs). Strips of graphene are ultra –
thin width (<50nm) (Fujita et al., 1996). Nanoparticles often possess unexpected optical 
properties as they are small enough to confine their electrons and produce quantum effects. 
2.2.2 Synthesis: 
There are two methods or approaches for synthesis of nanoparticles which includes physical 
approaches and chemical approaches. 
Physical approaches: Various metal nanoparticles such as silver, gold, sulphide, lead and 
cadmium are synthesised by physical approaches which includes evaporation-condensation 
and laser ablation. Evaporation-condensation method is mostly used for synthesis of 
nanoparticles as compared to laser ablation methods. This method uses tube furnace at 
atmospheric pressure. And this furnace tube require power consumption more than several 
kilowatts and a preheating time of several of tens of minute to reach a stable operating 
temperature.(Kruis et al., 2000: Magnusson et al., 1999). Physical methods are useful as 
nanoparticles generators for long terms experiments. 
Laser ablation methods: Nanoparticles are synthesised by laser ablation of metallic bulk 
materials in solution. The efficiency and characteristics of produced nanoparticles depend on 
wavelength of laser impinging the metallic target and duration of laser pulses (Mafune et al., 
2000). Important advantage of laser ablation technique as compared to other methods of 
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production of metals colloids is the absence of chemical reagents in solutions. Therefore, 
pure and uncontaminated metals are prepared by this technique (Tsuji et al., 2003). 
Chemical approaches: Most common approach for synthesis of nanoparticles is chemical 
reduction by organic and inorganic reducing agents. Sodium citrate, ascorbate, polyol 
process, tollens reagent, elemental hydrogen, etc. are the most common reducing agents. In 
this method it is important to use protective agent to stabilize dispersive nanoparticles during 
the course of metal nanoparticle preparation and protect the nanoparticles that can be 
absorbed on or bind onto nanoparticle surfaces and avoiding their agglomeration (Oliveira et 
al., 2005). 
2.2.3 Uses: 
Nanoparticles are mostly used in drug delivery systems like chemotherapy drugs directly to 
treat cancerous cell, gene delivery in gene therapy, detection of proteins, destruction of 
tumours with drugs or heat or biological detection of disease causing organism and diagnosis. 
Sometime nanoparticles are also used in probing of DNA structure. Nanoparticles of carbons 
are used for developing low cost electrodes for fuel cells. These electrodes may be able to 
replace the expensive platinum needed for fuel cell catalysts. Nanoparticles are used in 
labelling of bio-molecules such as antigen, antibody, DNA. Main function provided by 
nanoparticles is immobilisation of bio-molecules (Katz et al., 2004). Nanotechnology is also 
used in manipulation of cells and bio-molecules.  
2.3 PHOSPHOLIPIDS 
Phospholipids (a class of lipids) are the major component of all cell membrane as they form 
lipid layers. Phospholipids are amphipathic molecules but are soluble in water. They are also 
known as glycerol-phospholipids.  Phospholipids are composed of phosphate, two fatty acid 
and glycerol backbone. They consist of two region which includes polar region and non-polar 
region. Polar region of phospholipid  include glycerol or carbonyl of fatty acid and non polar 
region includes fatty acid. In former the polar region is also called as “Head region” and non-
polar region is called as “Tail region”. Not all phospholipids have ester linkage as the 
covalent bond in between the glycerol backbone and tail region. Generally, all mammalian 
tissue have qualitatively same phospholipids (Ansell et al., 1973).  
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2.3.1 Types of phospholipids: 
Some common phospholipids are phosphatidic acid (phosphatidate), 
phosphatidyethanolamine (cephalin), phosphatidylcholine (lecithin), phosphatidylserine, 
phosphoinositides, etc. Phospholipid synthesis occurs in the cytosol adjacent to endoplasmic 
reticulum (E Fahy et al., 2009). Common sources of phospholipids are chicken eggs, soya, 
sunflower, rapeseed, bovine milk, fish eggs. 
2.3.2 Uses:  
Phospholipid helps us to make a product that function as a second messenger in signal 
transduction (Crownshaw et al., 2006). Phospholipid can act as an emulsifier; it is also used 
as food additive and enables oils to form a colloid with water. Phospholipids are also used for 
drug delivery in medicine. Some phospholipids are also used as cosmetics. Example includes 
gold nano particles present in face cream which help in anti ageing. Omega -3 phospholipids 
has a tremendous health impact at cellular level. It acts as krill oil which is good for so many 
afflictions of body. Phospholipids stick together in unique pattern which allows to entry of 
oxygen and nutrient into the body but helps to keep bacteria or toxin out from the body. 
Omega -3 phospholipids has a tremendous health impact at cellular level. It acts as krill oil 
which is good for so many afflictions of body. Phospholipids stick together in unique pattern 
which allows to entry of oxygen and nutrient into the body but helps to keep bacteria or toxin 
out from the body. 
2.4 LIPOSOMES  
Liposomes are spherical, self closed vesicles of colloidal dimensions, in which phospho-lipid 
bilayer sequesters part of the solvent, in which they freely ﬂoat, into their interior (Bangham 
et al., 1964). The name liposome is derived from two Greek words: “lipo” meaning fat and 
“soma” meaning body. Liposomes are simple microscopic vesicles. Liposomes are a form of 
nanoparticle which is formed by using lecithin. It can be prepared by disrupting biological 
membrane or by sonication. Liposomes can be made entirely from naturally occurring 
substances and are therefore nontoxic, biodegradable and non immunogenic. In 1961, 
liposomes were first described by British haematologist Dr. Alec D Bangham FRS, at the  
Babraham Institute , in Cambridge. 
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2.4.1 Types: 
Liposomes can be classified on the basis of  
     i. Structural parameter,  
     ii. Method of preparation,  
    iii. Composition and  
    iv. Applications.  
 
On the basis of structural parameter the liposomes are classified into 4 types- multilamellar 
vesicles, oligolamellar vesicles, unilamellar vesicle. Multilamellar vesicles are less than 
0.5µm (>0.5µm) in size. Oligolamellar vesicles ranges between 0.1 to 1.0µm in size. 
Unilamellar vesicles are divided into two types which includes small unilamellar vesicles and 
large unilamellar vesicles. Small unilamellar vesicles range between 20 to 100nm. Large 
unilamellar vesicles ranges between greater than 100nm (>100nm) (Dua et al., 2012). 
 
Liposome are classified on the basis of method of preparation which includes Dehydration- 
rehydration methods. Unilamellar vesicles made by reverse phase evaporation method, 
multilamellar vesicles made by reverse phase evaporation, vesicles made by extrusion 
technique, frozen and thawed multilamellar vesicles and stable pluri-lamellar vesicles( Dua et 
al., 2012).  
On the basis of composition and application liposomes are classified into conventional 
liposomes these are negatively  or neutral charged phospholipids and cholesterols, fusogenic 
liposome, pH sensitive liposome, cationic liposome, long circulatory liposome and immune-
liposomes these are attached  with monoclonal antibodies. (Dua et al., 2012). 
2.4.2 Uses: 
Liposome has its own value in different fields. Liposomes are mostly used for drug delivery 
to targeted gene. Liposomes are also used in mathematics for topology in two dimensional 
surfaces in three dimensional surface governed only by bi-lipid elasticity. In biophysics 
liposomes are used for checking of the aggregation behaviour and fractal strength of 
materials. Liposomes are also used in chemistry for micro compartilization. In 
pharmaceuticals it is used for studies of drug actions (Lipowsky and Sackmann, 1995). 
Liposomes as drug delivery vehicles in medicine, adjuvants in vaccination, signal 
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enhancers/carriers in medical diagnostics and analytical biochemistry, solubilizers for various 
ingredients as well as support matrix for various ingredients and penetration enhancer in 
cosmetics (Lassic et al., 1992). Liposomes containing membrane anchored chelators can be 
used to clean toxic or radioactive metals from solutions. (Lassic., 1993).  Liposomes increase 
the efficiency, bioavailability, absorption of certain entrapped dietary and nutritional 
supplements and are used as topical drug delivery system (George et al., 1975). But 
liposomal drug delivery system has certain shortcomings like the need for modification for 
site specific or organ specific drug delivery, high production cost, leakage and fusion of 
encapsulated drug/molecule. Moreover unfavourable reactions like oxidation and hydrolysis 
of phospholipids reduces the half life of the formulation, decreases solubility and stability of 
drug in the medium (Sirisha.V.N et al., 2012). 
2.4.3 Demerits: 
They need much modification for drug delivery to special organ. Production cost is high. 
Leakage and fusion of encapsulated drug/molecules is a major problem. Sometimes 
phospholipids undergo oxidation and hydrolysis like reaction.  Liposome has very short half-
life, low solubility, and less stability. Liposomes in skin delivery have a limited ability to 
penetrate narrow blood vessels or into skin to. Sometimes the materials which we want to 
deliver into skin gets entrapped within the inner layers of the liposomes and in certain 
conditions are virtually un- releasable (Ralph hill, 2011). 
2.5 ETHOSOMES  
Ethosomes are soft and self closed vesicles. Ethosomes mainly consists of phospholipids, 
ethanol and water. These are malleable vesicles which are used for enhanced delivery of 
active agents. Ethosomes are non-invasive delivery carriers. Ethosome represents novel 
vesicular carrier for enhanced delivery through skin. Size of ethosome may vary from 30nm 
to a few microns. Ethosome has its ability to permeate intact through the human skin due to 
its high deformability. The physicochemical characteristic of ethosome allows this vesicular 
carrier to transport active substances more efficaciously through the stratum corneum into the 
deeper layers of the skin than conventional liposomes. Ethosome is mainly used for delivery 
of drug through transdermal route. 
2.5.1 Ethosome composition:  
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Ethosome are spherical vesicular consisting of phospholipids, water and ethanol. Typically 
ethosome comprises various types of phospholipid structures like hydrogenated 
phosphatidylcholine, phosphatidylcholine, phosphatidyl ethanolamine, phosphatidyl glycerol, 
phosphatidyl linositol, etc, with high concentration of ethanol or isopropyl alcohol. 
Sometimes dyes which includes amphiphilic fluroscent  probes such as –D289, Rhodamine-
123. Fluroscence isothiocyanate(FITC) are often  added to it for characterization study 
(Nikalje et al.,  2012).  
2.5.2 Effect of high concentration of ethanol: 
Alcohol or ethanol is an efficient permeation enhancer. In ethosome ethanol is present in 
quite high concentration i.e. 20 to 25 %. Due to its presence in high concentration ethosomes 
can easily disrupt the skin bi-lipid layers. Therefore, when integrated into a vesicle membrane 
it could give an ability to the vesicle to penetrate in skin (Dave and Pareek ,  2012). 
2.5.3 Uses: 
Ethosomes are mainly used for delivery of drug through transdermal route. Advantages of 
ethosome such as enhanced permeation of drug molecules to and through the skin, better 
stability; better solubility of many drugs as compared to conventional vesicles, contrary to 
deformation liposomes improves skin delivery of drugs. (Bharti et al., 2012). 
There are some common drugs administered by transdermal route like NSAIDS (Diclofenac), 
Acyclovir, Antibiotic, Cannabidol, Zidovudine, Ketoconazole. Ethosomal system is non-
invasive, passive and available for immediate commercialization. Ethosomes provide a large 
platform for drug delivery, its composition is safe and the components are approved for 
pharmaceutical and cosmetic use (Dave and Pareek, 2012 ).  Ethosomes are also used for 
pilosabeaceous targeting. Pilosabeacous is an epidermal invagination found on the most  
surfaces of human body and mostly composed of hair follicles and sebaceous glands. It has 
low risk profile (Jain et al., 2011). 
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2.6 KETOCONAZOLE: 
 
Ketoconazole is one of most important synthetic antifungal drug. Ketoconazole is an 
imidazole antifungal agent, it has a five membered ring structure containing two nitrogen 
atoms.  It is mostly used to treat fungal infection of skin. It belongs to azole family. Chemical 
formula of ketoconazole is C26H28Cl2N4O4 and its molecular weight is 531.43. Ketoconazole 
is marketed under trade name nizoral. Nizoral tablets contain the active ingredient of 
ketoconazole. It is usually prescribed for topical infection such as athlete’s foot, ringworm, 
candidiasis and jock itch. It is also used to treat fungal infection of scalp of hair i.e dandruff. 
Ketoconazole interferes with the fungal synthesis of ergosterols . Ergosterol and Cytochrome 
P450 14 alpha demethylase (P450 14 DM) enzyme is a constituent of fungal cell membrane 
(Loose et al., 1983). Ketoconazole inhibits p450 14 DM enzymes. This enzyme is in the 
sterol biosynthesis pathway that leads from lanosterol to ergosterol. The affinity of 
ketoconazole for fungal cell membranes is less compared to that of fluconazole an 
itraconazole. Ketoconazole has thus more potential to effect mammalian cell membranes and 
induce toxicity (Lewis et al., 1998). Nizoral tablets inhibit production of chemical called 
ergosterol, which is a componenet of fungal cell wall. Ketoconazole have no activity against 
Aspergillus spp., Fusarium spp., and zygomycetes order of fungi (Como et al., 1994). It may 
increase transaminase levels and hepatoxicity and may decrease testosterone and cortisol 
levels, resulting in gynecomastia and oligospermia in men and menstrual irregularities in 
women(O’connor et al., 2002). Ketoconazole also have antithyroid functions (Comby et al., 
1994). It is one of the least expensive drugs used for treatment of prostate cancer. 
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Chapter 3 
3.1 MATERIALS 
3.1.1 Chemicals Required: 
The drug ketoconazole was obtained from local pharmaceutical store under the brand name 
Nizoral. Lecithin (Trade name- Leciva- S70) containing not less than 98% phosphatidyl-
choline was received as a kind gift from VAV LIFE SCIENCES Pvt. Ltd, Mumbai, India. 
Ethanol and methanol was purchased from Hi-media Pvt. Ltd Mumbai, India. Distilled water 
and all other chemicals and solvents used in our work were of analytical grade and available 
in Department of Life Science, NIT Rourkela 
 
3.1.2 Instruments Used: 
The basic instruments used for the preparation and characterization of the samples like 
Weighing balance (Sartorius), Magnetic stirrer (Remi),  Probe Sonicator (Plexiglas), 
Refrigerated centrifuge (Eppendrof), Spectrophotometer (UV Lambda 35(R)Perkin Elmer) 
was available in the Department of Life Science, NIT Rourkela.  
Specialised facilities like Scanning Electron Microscopy, Atomic Force Microscopy, Particle 
Size Analyzer and FT-IR was kindly allowed by the Dept. of Metallurgical & Materials 
Engineering (MM), Dept. of Ceramic Engineering (CR) and Dept. of Chemistry (CY) 
respectively of NIT Rourkela. 
3.2 PREPARATION OF STOCK SOLUTION OF KETOCONAZOLE 
Ketoconazole stock solution was prepared by dissolving 1mg drug in 10 ml ethanol according 
to the manufacturer’s instruction. Working solutions of different concentrations ranging from 
0.3125µg/ml to 30 µg/ml were prepared from the stock solution.  
When water was used to dissolve the drug, it resulted in immediate precipitation of the drug, 
so the ethanol was chosen as a solvent. 
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3.3 PREPARATION OF ETHOSOME AND LIPOSOME 
3.3.1 Preparation of blank ethosomal particle:- 
Ethosome was prepared by solvent dispersion method as described by Touitou et.al. 2000.  
Briefly Lecithin (up to 2-3%), was dissolved in (30-40%) of 90% ethanol by use of magnetic 
stirrer (Remi Motors Mumbai) for 20 minutes at 100 rpm. To this mixture warm distilled 
water was slowly added in a fine stream by syringe and the whole system was stirred for 30 
minutes at 700 rpm. The resulting preparation was sonicated for 3 cycles of 5 minute each 
with 5 minute rest between the cycles. 
3.3.2 Preparation of drug (Ketoconazole) encapsulated ethosomes:- 
Ketoconazole (drug) encapsulated ethosomes were also prepared by solvent dispersion 
method following the protocol by Touitou et.al, 2000. Lecithin (2-3%) and ketoconazole was 
dissolved in (30-40%) of 90% ethanol by use of magnetic stirrer (Remi Motors Mumbai) for 
20 minutes at 100 rpm. Then warm distilled water was added slowly in a fine stream to the 
ethanolic drug mixture solution and the mixture was stirred for 30 minutes at 700 rpm in a 
closed vessel. The resulting preparation was sonicated for 3 cycles of 5 minute each with 5 
minute rest between the cycles. This method was repeated several times but by varying the 
drug concentration each time. 
3.3.3 Preparation of blank liposomal particle:- 
Liposomes were prepared by classic dispersion method as described by Touitou et.al. 2000 
with certain modifications. Lecithin (2-3%) was dissolved in 6 ml distilled water. This mix 
was heated to 30ᵒC in a water bath. To this mixture warm distilled water was added slowly in 
a fine stream with continuous stirring at 700 rpm in close vessel. The resulting vesicles were 
sonicated for 3 cycles of 5 minute each with 5 minute rest between the cycles. 
3.3.4 Preparation of drug (Ketoconazole) encapsulated liposomes:- 
Ketoconazole (drug) encapsulated liposomes were prepared as described by Touitou et.al, 
2000 with little modification of the classic dispersion method. Briefly lecithin (2-3%) and 
drug solution was taken and dissolved in 6 ml distilled water and this mix was heated to 30ᵒC 
in a water bath. Warm distilled water was added slowly in a fine stream to the drug-lipid 
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suspension with continuous stirring at 700 rpm in a closed vessel. The resulting vesicles were 
sonicated for 3 cycles of 5 minute each with 5 minute rest between the cycles. 
3.4 Various methods of characterizations of ethosome and liposome.  
3.4.1 SEM (scanning electron microscope) Analysis: 
To study vesicle shape or morphology of ethosome and liposome can be done by using 
scanning electron microscope. Ethosome and liposomes vesicles were visualised using Jeol 
6480 LVJSM electron microscope. For SEM one drop of each sample from ethosome and 
liposome were mounted on a stub covered with clean glass respectively. The drop was spread 
out on the glass homogenously. A sputter coater was used to sputter coat the samples with 
platinium and samples were examined under Jeol 6480 LVJSM at an accelerating voltage 
20kv. 
3.4.2 Vesicle size and Zeta potential Analysis: 
Zeta potential is an important and useful indicator of particle surface charge, which can be 
used to predict and control the stability of sample. Zeta potential is a physical property which 
is exhibited by any particles in suspension it can be used to optimize the formulation of 
suspension and emulsion. 
3.4.3 Determination of drug encapsulating capacity: 
Determination of drug encapsulating capacity of ethosome can be determined by mini column 
centrifugation method or fluorescence spectrophotometer, but we utilised the fluorescence 
spectrophotometer method. First derivatives of UV spectrum of ketoconazole, in a range from 
211nm to 295nm, presented a maximum absorption peak at 257nm,without any interference 
from excipients. Method was validated at the 244nm. Analytical curve was constructed in 
concentration range from 0.3125ug to 30ug. Spectrophotometer (UV-Lambda 35(R) was 
Perkin Elmer, Waltem ms USA). The % drug content of ethosomal preparation was 
determined  by using following formula 
 
 
  
%of drug content=sample absorbance/standard absorbance 
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Entrapment efficiency: 
The entrapment efficiency of ketoconazole ethosome was measured by the ultracentrifugation 
method. Vesicular preparation containing ketoconazole was kept overnight at 4ᵒC and  
centrifuge in ultra centrifugation  4ᵒC at 30,000 rpm for 2 hrs. Ketoconazole was assayed in 
both sediment and supernatant. The entrapment efficiency was calculated using following 
formula 
 
 
 
3.5 Antifungal activity: 
Fungal culture was inoculated into test tube containing PDB (potato dextrose broth) and 
incubated at 28ᵒC for 2-3 days. 100 µl of the broth culture was added onto a slide and the 
slide was put in the prepared PDA plates. Wells were punctured onto the agar plates and 
100µl of various concentrations of suspensions were loaded into the wells and incubated for 
3-4 days. After 3-4 days, the area in the plate with no fungal growth was measured.  
 
 
 
 
 
 
 
 
 
 
 
%entrapment efficiency= Amount of drug added –amount 
of drug non encapsulated *100/amount of drug loaded.  
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Table 3.1 Composition of working solutions: 
Concentration 0.1M HCL Drug Stock Solution 
30 µg/ml 1400 µl 600 µl 
25 µg/ml 1500 µl 500 µl 
20 µg/ml 1600 µl 400 µl 
15 µg/ml 1700 µl 300 µl 
10 µg/ml 1800 µl 200 µl 
5 µg/ml 1900 µl 100 µl 
2.5 µg/ml 1950 µl 50 µl 
1.25 µg/ml 1975 µl 25 µl 
0.625 µg/ml 1998.75 µl 12.5 µl 
0.3125 µg/ml 1993.75 µl 6.25 µl 
 
Table 3.2 Composition of blank liposome: 
Lecithin  Distilled water Distilled water Total volume 
0.6ml 6ml 13.4ml 20ml 
 
Table 3.3 Composition of drug encapsulated liposomes: 
Drug Concentration  Lecithin Distilled water Drug solution Total volume 
30 µg/ml 0.6ml 17.4ml 2ml 20ml 
20 µg/ml 0.6ml 17.4ml 2ml 20ml 
10 µg/ml 0.6ml 17.4ml 2ml 20ml 
5 µg/ml 0.6ml 17.4ml 2ml 20ml 
 
Table 3.4 composition of blank ethosome: 
Lecithin  Ethanol Distilled water Total volume 
0.6ml 6ml 13.4ml 20ml 
 
Table 3.5 Composition of drug encapsulated ethosome: 
Drug 
Concentration  
Lecithin Ethanol  Drug solution Distilled 
water 
Total volume 
30 µg/ml 0.6ml 6ml 2ml 11.4ml 20ml 
20 µg/ml 0.6ml 6ml 2ml 11.4ml 20ml 
10 µg/ml 0.6ml 6ml 2ml 11.4ml 20ml 
5 µg/ml 0.6ml 6ml 2ml 11.4ml 20ml 
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Chapter 4 
RESULTS 
The various formulations of liposomes and ethosomes were characterized and their results 
shown below. 
 4.1 Vesicle Morphology: 
The various drug loaded formulations of ethosomes and liposomes (including the blank 
particles) appeared more or less spherical when observed by SEM (Fig. 1).  
4.2 Particle size and particle size distribution: 
The particle size, zeta potential and size distribution of the various suspensions are shown in 
Table 4.1. The zeta potential of all the ethosomal vesicles was of higher magnitude than 
liposomal vesicles (measured in milivolts). The poly index measured in PDI and particle size 
measured in nanometre. 
4.3 Drug Entrapment Efficiency: 
The entrapment efficiency was calculated as mentioned in Chapter 3. The quantity of drug 
entrapped is more in case of ethosome as compared to liposome. Among the various 
formulations when drug concentration is around 20-30 µg/ml, the quantity of drug entrapped 
is more. The high ethanol concentration favoured better encapsulation. The values of 
encapsulation efficiency is shown in Table 4.4. 
4.4 Antifungal Studies: 
The in-vitro antifungal studies qualitatively showed the better efficacy of drug loaded 
ethosomes against the drug loaded liposomes. The blank formulations did not show any 
activity against the fungal pathogens. The results are shown in Fig.4.13.  
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Fig 4.1.Concentration of drug 5µg/ml 
          
                 Liposome                                                              Ethosome 
Fig 4.2. Concentration of drug 10µg/ml 
                    
                 Liposome                                                                            Ethosome  
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Fig 4.3.Concentration of drug 20µg/ml  
       
                     Liposome                                                          Ethosome 
 
Fig 4.4. Concentration of drug 30µg/ml 
       
                      Liposome                                                         Ethosome 
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Fig 4.6. Size and zeta potential of liposome 20  
 
Fig 4.5. Size and zeta potential of liposome 30
  
 
Fig 4.7. Size and zeta potential of liposome 10 
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Fig 4.8. Size and zeta potential of liposome 5 
   
Fig 4.9. Size and zeta potential of ethosome 30 
  
Fig 4.10. Size and zeta potential of ethosome 20 
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Fig 4.11. Size and zeta potential of ethosome 10 
    
Fig 4.12. Size and zeta potential of ethosome 5 
   
Fig 4.13 Antifungal activity shown by liposome(A) and ethosome(B) 
A B 
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Table 4.1 Vesicle size and zeta potential of the formulations  
Drug encapsulated 
sample(liposome and 
ethosome) 
Particle size(nm) Zeta potential (mV) Poly dispersity 
Index (PdI) 
Charges 
Liposome30µg/ml 61.23 -29.0 0.351 Negative 
Liposome 20 µg/ml 52.34 -12.2 0.418 Negative 
Liposome 10 µg/ml 187.1 -16.5 0.673 Negative  
Liposome 5 µg/ml 58.65 -72.8 0.396 Negative 
Ethosome 30 µg/ml 133.9 -56.2 0.212 Negative 
Ethosome 20 µg/ml 131.5 -19.4 0.249 Negative 
Ethosome 10 µg/ml 50.61 -52.85 0.530 Negative 
Ethosome 5 µg/ml 42.86 0.00508 0.383 Negative 
 
Table 4.2 Absorbance of the different conc. of drug (ketoconazole) at 224 nm  
Concentration  
 
OD1 OD2 Mean of OD1 and 
OD2 
30 µg/ml 1.836  1.786  1.811  
25 µg/ml 1.512  1.501  1.506  
20 µg/ml 1.206  1.202  1.204  
15 µg/ml 0.917  0.903  0.910  
10 µg/ml 0.578  0.579  0.578  
5 µg/ml 0.300  0.280  0.290  
2.5 µg/ml 0.129  0.119  0.124  
1.25 µg/ml 0.050  0.047  0.0485  
0.625 µg/ml 0.010  0.009  0.0095  
0.3125 µg/ml -0.001 -0.008  -0.0045 
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Table 4.3 OD of supernatant of emulsions  
Drug Concentration in 
µg/ml  
 
O.D of Liposome  
 
O.D of Ethosome  
 
30 µg/ml 0.413  0.433  
20 µg/ml 0.392  0.395  
10 µg/ml 0.257  0.280  
5 µg/ml 0.25  0.233  
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Fig 4.14. Standard Curve 
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Table 4.4 Concentration of drug in supernatant and sediment and determination of 
encapsulation efficiency  
Sample Name  Conc. of drug in 
supernatant µg/ml  
Conc. of drug in 
sediment µg/ml  
Encapsulation 
efficiency(%)  
Liposome30 µg/ml 7.4  22.6  75.33  
Ethosome 30 µg/ml 7.1  22.9  76.33  
Liposome 20 µg/ml 6.828  13.17  65.85  
Ethosome 20 µg/ml 6.77  13.23  66.15  
Liposome10 µg/ml 4.95  5.05  50.5  
Ethosome 10 µg/ml 4.577  5.423  54.23  
Liposome 5 µg/ml 4.18  0.82  16.4  
Ethosome 5 µg/ml 4.055  0.94  18.8  
 
 
                  30µg/ml                  20 µg/ml                  10 µg/ml                  5 µg/ml           
                                           
Fig  4.15. Graph showing comparative encapsulation efficiency of ethosome and liposome 
at various drug concentrations 
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Chapter 5 
DISCUSSION  
 
Development of novel drug delivery carriers are a necessity to deliver the drugs to target site 
at a faster rate to overcome the drawbacks of multi-dose therapy and increase patient 
compliance and improve their safety. For drug delivery via dermal and transdermal routes 
ethosomes have emerged as a non-invasive mean. 
5.1 Vesicle morphology: 
The SEM morphology shows the formation of uniform, more or less spherical vesicular 
structures in case of ethosome. Encapsulation of ketoconazole can be clearly observed within 
the vesicles. Better encapsulation has been observed in case of ethosomes with higher 
concentration of drug i.e. 20-30µg/ml. Liposomal suspension also showed spherical 
morphology in the SEM micrograph. But mostly the particles were found in an aggregated 
manner. Hence the SEM Micrograph show better formation and encapsulation by ethosome 
as compared to liposome. 
It can also be observed that high ethanol concentration is responsible for stable vesicles. This 
finding is supported by Lasic et al., who proposed that ethanol causes a modification of net 
charge of the vesicular system and confers on it some degree of steric stabilization. 
5.2 Particle size and particle potential: 
The zeta potential of the ethosomal suspensions were mostly in the range of -43.4 mV to 59.4 
mV which indicated good stability. But the zeta potential values of liposomes ranged between 
-12.2 mV to -29.0 mV indicating incipient stability. Similarly the PDI values of ethosome 
and liposome lie in the range 0.212- 0.383 and 0.351- 0.673 respectively. This value helps to 
determine whether the suspension is mono-dispersed or poly-dispersed. Generally if the PDI 
value lies between 0.00-0.5. the suspension is considered mono-dispersed, while PDI values 
greater than 0.5 indicates poly-dispersed suspension. So from the above values we observe 
the ethosomal suspensions are mono-dispersed while the liposomal formulations may be 
monodispersed or poly-dispersed.  
Stable and smaller ethosomes may be due to formation of hydrocarbon phase with inter-
penetrating properties (touitou et al., 2000).  
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The high negative charge on ethosomes is dependent on two factors: (i) ethanol, which 
provides a net negative surface charge thus avoiding aggregation of vesicles due to 
electrostatic repulsion; and (ii) lecithin, which provides a greater rigidity to the layers and 
reduced likelihood of vesicles fusion, as well as a greater resistance to the high rotational 
energy exerted by sonication, resulting in a high negative charge (Verma P et al.,2011). 
5.3 Drug entrapment efficiency: 
The graph showed better encapsulation by ethosomes as compared to liposomes in each 
concentration range. This may be due to better solubility of the drug in ethanol. Moreover 
higher the concentration of drug solution used higher was the encapsulation efficiency.  
Our results showing higher encapsulation efficiency and stability in case of Ethosomal 
formulations is in compliance with results of other research groups (Dubey et al., 2007). High 
encapsulation efficiency and stability is due to better solubility and retentivity if the drug 
Ketoconazole in ethanol (Touitou et al., 2000). 
5.4 Antifungal activity: 
Area inhibited was more in case of ethosomal suspension as compared to liposomal 
formulation. This may be due to the extra potential of ethanol to kill organisms by denaturing 
their proteins and dissolving their lipids, apart from skin fluidization and penetration 
McDonnell and Russell, 1999).  
From this analysis we can assume that ethanol containing formulation will prove as a better 
carrier system and a therapeutically promising candidate for the efficient treatment of fungal 
infection over surfactant based formulations (liposome). 
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Chapter 6 
CONCLUSION  
The ethosomal formulations were more spherical with stable zeta potential and mono-
disperse with no clumping. Although the liposomes showed spherical morphology but were 
less stable and usually poly-dispersed in nature. The antifungal activity of liposome was less 
as compared to ethosomes.  
So from the study it was confirmed that ethosomal formulation of ketoconazole showed a 
good entrapment efficiency and better stability profile as compared to liposomes. Thus it is 
concluded that ethosomal formulation is a very promising option for transdermal delivery and 
has potential for new opportunities for topical application of ketoconazole in the fungal 
infections. 
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